Persistence of secondary hyperparathyroidism after parathyroidectomy in a patient with chronic kidney disease: a case report

This is a clinical case of surgical treatment of persistence of secondary hyperparathyroidism (SHPT) in a patient with chronic kidney disease after previous parathyroidectomy. Programmed hemodialysis started in 2014, and in 2016 SHPT was diagnosed. In November 2018, indications for surgical treatment were presented in one of the clinics. According to scintigraphy, an increase in the functional activity of all four parathyroid glands (PTG) was observed, according to ultrasound data, the localization of the right lower, left upper and lower PTG was established. Removal of 3x PTG was performed without revision of the thymus horns (11.2018), while in the postoperative period, an adequate decrease in parathyroid hormone was not observed. After additional examination, according to ultrasound, scintigraphy and computer tomography of the neck with intravenous enhancement, it was found that both lower PTGs are located in the upper horns of the thymus. In July 2020, a repeated surgical intervention was performed in the volume of the right lower and left lower parathyroidectomy with a positive intraoperative test. Remission of SHPT was achieved. At present, no consensus has been reached on the extent of surgery for SHPT, since no statistically significant differences were found in the incidence of persistence / recurrence of SHPT. A complete assessment of the results of preoperative imaging techniques is required when planning surgery. Intraoperative monitoring of parathyroid hormone is an effective technique for assessing the radicality of surgical treatment.

1. Dedov II, Mel’nichenko GA. Endokrinologiya. Klinicheskie rekomendatsii. Moscow: GEOTAR-Media; 2017. (In Russ.).

2. Bikbov BT, Tomilina NA. Zamestitel’naya terapiya bol’nykh s khronicheskoi pochechnoi nedostatochnost’yu metodami peritoneal’nogo dializa i transplantatsii pochki v Rossiiskoi Federatsii v 1998–2011 gg. Nefrologiya i dializ. 2014;16(2):192-227. (In Russ.).

3. Association of Nephrology, Scientific Society of Nephrology of Russia, Ermolenko VM, Vetchinnikova ON, Volgina GV, Gurevich KY, Tomilina NA, Fedoseev AN, Shutov EV, Andrusev AM, Zemchenkov AY, Kotenko ON, Mikhaylova NA, Ryasnyanskiy VY, Shilo VY, Gerasimchuk RP. 2015. Mineral and bone disorders in chronic kidney disease. National recommendations. Available from: http://www.nephro.ru/content/files/recomendations/ckdmbdNationalGuidelines.pdf. (In Russ.).

4. Bikbov B, Bieber B, Andrusev A, et al. Hemodialysis practice patterns in the Russia Dialysis Outcomes and Practice Patterns Study (DOPPS), with international comparisons. HemodialysisInt. 2017;21(3):393-408. doi: https://doi.org/10.1111/hdi.12503

5. Gerasimchuk RP, Zemchenkov AY, Novokshonov KY, et al. Influence of parathyroidectomy on the dynamics of laboratory indicators of MBD of CKD and survival of patients receiving renal replacement therapy in St. Petersburg. Nefrologiya i dializ. 2016;18(1):40-49. (In Russ.).

6. Tsai W, Tsai W, Peng Y, et al. Short — and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients: A 12-Year Single-Center Experience. BloodPurif. 2013;36:116-121. doi: https://doi.org/10.1159/000353415

7. Egshatyan LV, Mokrisheva NG, Rozhinskaya LY. Secondary and tertiary hyperparathyroidism in chronic kidney disease. Osteoporos Bone Dis. 2017;20(2):63-68. (In Russ.). doi: https://doi.org/10.14341/osteo2017263-68

8. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1-59. doi: https://doi.org/10.1016/j.kisu.2017.04.001

9. Velichko AV, Yarets YI, Zyblev SL, et al. Effect of Parathyroidectomy on the Bone Metabolism Indicators in Patients with Secondary Hyperparathyroidism Against the Background of Chronic Renal Disease. Nov Khirurgii. 2016;24(1):32-39. (In Russ.). doi: https://doi.org/10.18484/2305-0047.2016.1.32.

10. Rothmund M, Wagner PK, Schark C. Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: A randomized trial. World J Surg. 1991;15(6):745-750. doi: https://doi.org/10.1007/BF01665309

11. Schneider R, Slater EP, Karakas E, et al. Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg. 2012;36(2):318-326. doi: https://doi.org/10.1007/s00268-011-1392-0

12. Steffen L, Moffa G, Müller PC, Oertli D. Secondary hyperparathyroidism: recurrence after total parathyroidectomy with autotransplantation. Swiss Med Wkly. 2019;149:w20160. doi: https://doi.org/10.4414/smw.2019.20160

13. Sari R, Yabanoglu H, Hargura AS, et al. Outcomes of Total Parathyroidectomy with Autotransplantation versus Subtotal Parathyroidectomy Techniques for Secondary Hyperparathyroidism in Chronic Renal Failure. J Coll Physicians Surg Pak. 2020;30(1):18-22. doi: https://doi.org/10.29271/jcpsp.2020.01.18

14. Liu ME, Qiu NC, Zha SL, et al. To assess the effects of parathyroidectomy (TPTX versus TPTX+AT) for Secondary Hyperparathyroidism in chronic renal failure: A Systematic Review and Meta-Analysis. Int J Surg. 2017;44:353-362. doi: https://doi.org/10.1016/j.ijsu.2017.06.029.

15. Abruzzo A, Gioviale MC, Damiano G, et al. Reoperation for persistent or recurrent secondary hyperparathyroidism. Acta Biomed. 2017;88(3):325-328. doi: https://doi.org/10.23750/abm.v88i3.4722

16. Konturek A, Barczyński M, Stopa M, Nowak W. Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbecks Arch Surg. 2016;401(7):965-974. doi: https://doi.org/10.1007/s00423-016-1447-7

17. Sakman G., Parsak C.K., Balal M. Outcomes of Total Parathyroidectomy with Autotransplantationversus Subtotal Parathyroidectomy with Routine Addition of Thymectomy to both Groups: Single Center Experience of Secondary Hyperparathyroidism. Balkan Medical Journal. 2014;31(1):77-82. doi: https://doi.org/10.5152/balkanmedj.2014.9544

18. Uludag M., Yetkin G., Citgez B. The role of cervical thymectomy in surgical treatment of secondary hyperparathyroidism. BratislLekListy. 2011;112(7):385-389

19. Hiramitsu T, Tomosugi T, Okada M, et al. Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study. Sci Rep. 2019;9(1):14634. doi: https://doi.org/10.1038/s41598-019-51265-y

20. Chen YH, Chen HT, Lee MC, et al. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound. Ann Nucl Med. 2020;34(8):527-537. doi: https://doi.org/10.1007/s12149-020-01479-2

21. Zhang R, Zhang Z, Huang P, et al. Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism. BMC Med Imaging. 2020;20(1):91. doi: https://doi.org/10.1186/s12880-020-00490-3

22. Jiang SQ, Yang T, Zou Q, et al. The role of 99mTc-MIBI SPECT/CT in patients with secondary hyperparathyroidism: comparison with 99mTc-MIBI planar scintigraphy and ultrasonography. BMC Med Imaging. 2020;20(1):115. doi: https://doi.org/10.1186/s12880-020-00517-9

23. Li X, Li J, Li Y, et al. The role of preoperative ultrasound, contrast-enhanced ultrasound, and 99mTc-MIBI scanning with single-photon emission computed tomography/X-ray computed tomography localization in refractory secondary hyperparathyroidism. Clin Hemorheol Microcirc. 2020;75(1):35-46. doi: https://doi.org/10.3233/CH-190723

24. Chen J, Jia X, Kong X, et al. Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis. Nephrology (Carlton). 2017;22(5):388-396. doi: https://doi.org/10.1111/nep.12801

25. Schlosser K, Bartsch DK, Diener MK, et al. Total Parathyroidectomy With Routine Thymectomy and Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism: Results of a Nonconfirmatory Multicenter Prospective Randomized Controlled Pilot Trial. Ann Surg. 2016;264(5):745-753. doi: https://doi.org/10.1097/SLA.0000000000001875

26. Sakman G, Parsak CK, Balal M. Outcomes of Total Parathyroidectomy with Autotransplantationversus Subtotal Parathyroidectomy with Routine Addition of Thymectomy to both Groups: Single Center Experience of Secondary Hyperparathyroidism. Balkan Medical Journal. 2014;31(1):77-82. doi: https://doi.org/10.5152/balkanmedj.2014.9544

27. Weber T, Zeier M, Hinz U. Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism. World Journal of Surgery. 2005;29(9):1176-1179. doi: https://doi.org/10.1007/s00268-005-7805-1

28. Damiano G, Gioviale MC, Maione C. Comparison Between Rapid Intraoperative and Central Laboratory Parathormone Dosage in Kidney Transplant Candidates. Transplantation Proceedings. 2016;48(2):311-314. doi: https://doi.org/10.1016/j.transproceed.2016.02.003

29. Vulpio C, Bossola M, Di Stasio E. Intraoperative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. Clinical Biochemistry. 2016;49(7-8):538-543. doi: https://doi.org/10.1016/j.clinbiochem.2016.01.012

30. Ilyicheva EA, Bulgatov DA, Zharkaya AV, et al. Experience of surgical treatment of secondary hyperparathyroidism with intra-operational monitoring of parathyroid hormone. Tavricheskiy mediko-biologicheskiy vestnik. 2017;20(3):46-51. (In Russ.).

31. Ge Y, Yang G, Wang N, Zha X, et al. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol. 2019;51(8):1443-1449. doi: https://doi.org/10.1007/s11255-019-02217-y

32. Latus J, Roesel M, Fritz P, et al. Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis. 2013;6:131-137. doi: https://doi.org/10.2147/IJNRD.S47179

33. Mittendorf EA, Merlino JI, McHenry CR. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg. 2004;70(2):114-119.

34. Grebennikova TA, Belaya ZE, Melnichenko GA. Hypoparathyroidism: disease update and new methods of treatment. Endocrine Surgery. 2017;11(2):70-80. (In Russ.). doi: https://doi.org/10.14341/serg2017270-80

35. Su A, Gong Y, Wu W, et al. Effect of autotransplantation of a parathyroid gland on hypoparathyroidism after total thyroidectomy. Endocr Connect. 2018;7(2):286-294. doi: https://doi.org/10.1530/EC-17-0313

36. Neagoe RM, Mureșan M, Voidăzan S, et al. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplant in secondary hyperparathyroidism — a single-centre prospective cohort of 43 patients. Endokrynol Pol. 2016;67(2):202-209. doi: https://doi.org/10.5603/EP.a2016.0013

37. Veyrat M, Fessi H, Haymann JP, et al. Conservative three-quarter versus subtotal seven-eighths parathyroidectomy in secondary hyperparathyroidism. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136(2):63-68. doi: https://doi.org/10.1016/j.anorl.2018.09.003

38. Brandenburg VM, Floege J. Adynamic bone disease-bone and beyond. Clin Kidney J. 2008;1(3):135-147. doi: https://doi.org/10.1093/ndtplus/sfn040

39. Hruska KA, Teitelbaum SL. Renal Osteodystrophy. N Engl J Med. 1995;333(3):166-175. doi: https://doi.org/10.1056/NEJM199507203330307

40. London GM. Arterial Calcifications and Bone Histomorphometry in End-Stage Renal Disease. J Am Soc Nephrol. 2004;15(7):1943-1951. doi: https://doi.org/10.1097/01.ASN.0000129337.50739.48

41. Jia X, Wang R, Zhang C, et al. Long-Term Outcomes of Total Parathyroidectomy With or Without Autoimplantation for Hyperparathyroidism in Chronic Kidney Disease: A Meta-Analysis. Ther Apher Dial. 2015;19(5):477-485. doi: https://doi.org/10.1111/1744-9987.12310